Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Change in Accured Expenses (2020 - 2023)

Avai Bio's Change in Accured Expenses history spans 3 years, with the latest figure at $440000.0 for Q4 2023.

  • For Q4 2023, Change in Accured Expenses rose 1366.67% year-over-year to $440000.0; the TTM value through Dec 2023 reached $660500.0, up 34501.04%, while the annual FY2023 figure was $1600.0, 64.61% up from the prior year.
  • Change in Accured Expenses for Q4 2023 was $440000.0 at Avai Bio, up from -$48600.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $440000.0 in Q4 2023 and bottomed at -$48600.0 in Q3 2023.
  • The 3-year median for Change in Accured Expenses is $3100.0 (2023), against an average of $74261.2.
  • The largest YoY upside for Change in Accured Expenses was 12530.58% in 2023 against a maximum downside of 44.62% in 2023.
  • A 3-year view of Change in Accured Expenses shows it stood at -$420.0 in 2020, then soared by 7242.86% to $30000.0 in 2022, then surged by 1366.67% to $440000.0 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Change in Accured Expenses are $440000.0 (Q4 2023), -$48600.0 (Q3 2023), and $266000.0 (Q2 2023).